Vaxart, Inc. (VXRT) Financial Statements (2024 and earlier)

Company Profile

Business Address 170 HARBOR WAY, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
6/30/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:95,70022,742126,87013,52611,50638,600
Cash and cash equivalents 44,013 126,87013,52611,50617,700
Short-term investments49,70422,742   20,900
Other undisclosed cash, cash equivalents, and short-term investments1,983     
Receivables20713343,6191,796600
Contract with customer, asset, after allowance for credit loss    181 
Other undisclosed current assets3,731146,3541,3272721,343700
Total current assets:99,451169,167128,53117,59814,64539,900
Noncurrent Assets
Operating lease, right-of-use asset25,71513,1686,8381,990
Property, plant and equipment15,5856,6011,4802101,066200
Long-term investments and receivables  16,210    
Long-term investments  16,210    
Intangible assets, net (including goodwill)9,52815,13215,36117,09319,413 
Goodwill4,5084,508    
Intangible assets, net (excluding goodwill)5,02010,62415,36117,09319,413 
Other noncurrent assets3,568890372141103 
Total noncurrent assets:54,39652,00124,05119,43420,582200
TOTAL ASSETS:153,847221,168152,58237,03235,22740,100
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,5988,9366,9325,4172,4804,300
Accounts payable5,5143,8722,1338529621,400
Accrued liabilities8,0845,0644,7994,5651,5182,900
Deferred revenue2,000   
Debt    841 200
Deferred revenue and credits1,400
Other undisclosed current liabilities2,3231,8474,8312,9164,995 
Total current liabilities:17,92110,78311,7639,1747,4755,900
Noncurrent Liabilities
Long-term debt and lease obligation  11,9975,1561,4721,944100
Long-term debt, excluding current maturities     1,944100
Liabilities, other than long-term debt19,7081711091815715,400
Deferred revenue and credits15,300
Other liabilities23117110918157100
Operating lease, liability19,47711,9975,1561,472
Other undisclosed noncurrent liabilities5,62110,68612,15013,41614,413 
Total noncurrent liabilities:25,32922,85417,41514,90616,51415,500
Total liabilities:43,25033,63729,17824,08023,98921,400
Equity
Equity, attributable to parent110,597187,531123,40412,95211,23818,700
Common stock1313114,8257143,900
Treasury stock, value      
Additional paid in capital437,992406,943272,274124,788108,513159,600
Accumulated other comprehensive income (loss)(299)(74)   19,000
Accumulated deficit(327,109)(219,351)(148,881)(116,661)(97,989)(163,800)
Total equity:110,597187,531123,40412,95211,23818,700
TOTAL LIABILITIES AND EQUITY:153,847221,168152,58237,03235,22740,100

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
6/30/2017
Revenues1078924,0469,8624,1598,900
Revenue, net5,700
Gross profit:1078924,0469,8624,1598,900
Operating expenses(114,694)(73,644)(34,216)(25,647)(25,915)(36,400)
Operating loss:(114,587)(72,752)(30,170)(15,785)(21,756)(27,500)
Nonoperating income (expense)(6)(1)(13)(2,370)3,858(1,600)
Investment income, nonoperating     6,818 
Loss, foreign currency transaction, before tax(6)(1)(13)(32)(266) 
Other nonoperating income (expense)     200
Interest and debt expense    (100)(821) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   (1,799)100821 
Loss from continuing operations before equity method investments, income taxes:(114,593)(72,753)(31,982)(18,155)(17,898)(29,100)
Other undisclosed income from continuing operations before income taxes6,9022,390    
Loss from continuing operations before income taxes:(107,691)(70,363)(31,982)(18,155)(17,898)(29,100)
Income tax expense(67)(107)(238)(490)(109)(300)
Loss from continuing operations:(107,758)(70,470)(32,220)(18,645)(18,007)(29,400)
Loss before gain (loss) on sale of properties:(70,470)(32,220)(18,645)(18,007)(29,400)
Net loss attributable to parent:(107,758)(70,470)(32,220)(18,645)(18,007)(29,400)
Preferred stock dividends and other adjustments     (339) 
Net loss available to common stockholders, diluted:(107,758)(70,470)(32,220)(18,645)(18,346)(29,400)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
6/30/2017
Net loss:(107,758)(70,470)(32,220)(18,645)(18,007)(29,400)
Comprehensive loss:(107,758)(70,470)(32,220)(18,645)(18,007)(29,400)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(225)(74)    
Comprehensive loss, net of tax, attributable to parent:(107,983)(70,544)(32,220)(18,645)(18,007)(29,400)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: